CLVLY Clinuvel Pharmaceuticals Limited Sponsored ADRs

Clinuvel Pharmaceuticals Ltd. is a global biopharmaceutical company. It engages in the the development of SCENESSE, its proprietary photoprotective drug. It also offers drugs for the treatment of various skin disorders. The company was founded by Robert Thomas Dorr on December 14, 1999 and is headquartered in Melbourne, Australia. This is an ADR of a company whose stock trades outside of the U.S. as the symbol AT:CUV.

This security is traded over-the-counter, or OTC. We don't always have accurate pricing data on OTC stocks.

$15.89    Pink
As of 01/27/2022     OTCMarkets


Security Information
Category1:  US Equity
Category2:  ADRs
Category3:  Small cap
GICS sector:  Health Care
Industry:  Biotechnology
Index country:  Australia
Country of incorporation:  Australia
IPO date:  06/30/2004
Outstanding shares:  49,410,338
Average volume:  6,288
Market cap:   $808,353,130
Current dividend yield:  0.11%
All SEC filings:     SEC Edgar Online
Quarterly filings:   10-Q
Annual filings:      10-K
Sedol:      
Valuation   (See tab for details)
PE ratio:   53.47
PB ratio:   8.19
PS ratio:   25.23
Return on equity:   15.31%
Net income %:   47.19%

2022 © Stock Market MBA, Inc. Terms of use | Privacy policy